Biotech news, week of August 17, 2026

Monday, August 17, 2026

1. 0123:03 UTC

   TekniPlex Brings 3 Precision Tubing Lines to China's Medtec 2026

   3 outlets · first: financialpost.com Pharma Mostly press releases

   Machine summary The company claims nearly 60 years of materials-science expertise and local China manufacturing, which could affect drug delivery, diagnostics, and interventional therapy supply chains.

   1. TekniPlex Healthcare announced that it will be exhibiting at Medtec China 2026, set to occur September 1–3, 2026, at SNIEC, which is the Shanghai New International Expo Centre.
   2. The company's exhibit, at Booth 2A112, Hall N2, will showcase medical silicone pump tubing, Para-tubing for ophthalmic applications, and PTA/PTCA precision interventional tubing.
   3. TekniPlex claims nearly 60 years of materials science expertise and a strong local presence in China for medical devices, diagnostics, drug delivery, and healthcare packaging.
   4. The silicone pump tubing is promoted for peristaltic pumps, infusion pumps, and fluid-management devices, with claimed elasticity, fatigue resistance, and long-term performance stability.
   5. Para-tubing is positioned for ophthalmic minimally invasive surgical devices requiring precision fluid management and compact multi-line configurations.

   Reported by financialpost.com, thestarphoenix.com and manilatimes.net.

   • Para-tubing
   • PTA/PTCA precision interventional tubing
   • Medtec China 2026
   • Medtec China
   • Medical silicone pump tubing
   • TekniPlex Healthcare

Tuesday, August 18, 2026

1. 0220:45 UTC

   Study reports longer US cancer treatment waits

   2 outlets · first: fox32chicago.com Clinical trial

   Machine summary A study published in JAMA Surgery reported that median wait times from cancer diagnosis to first treatment grew by more than 10 days across six common cancers among US adults diagnosed between January 2012 and December 2023. According to the reports, a team from Massachusetts General Hospital and the University of California, Los Angeles examined nationwide data covering over two million patients.

   1. According to the reports, the research, which appeared in JAMA Surgery, examined nationwide data on over two million patients whose diagnoses occurred from January 2012 through December 2023.
   2. The reports said the research followed adults who had breast, colon, stomach, pancreatic, esophageal, or lung cancer at stages ranging from early to locally advanced, and who underwent surgery during the initial phase of their treatment.
   3. Median wait times grew by more than 10 days across all six cancer types over the study period, according to the reports.
   4. The reports said stomach cancer waits rose from 35 to 49 days and lung cancer waits from 41 to 53 days, among other increases.
   5. Dr. Marc Siegel, a Fox News senior medical analyst not involved in the study, told Fox News Digital that this is part of the healthcare system that needs fixing immediately, according to the reports.

   Reported by fox32chicago.com and Fox 7 Austin.

   • Fox News Digital
   • University of California, Los Angeles
   • Massachusetts General Hospital
   • JAMA Surgery

Wednesday, August 19, 2026

4 events. The full rundown for August 19, 2026. The most covered:

1. 01:18 UTC Kstp Television: “The Latest: Trump picks top White House aide Dr. Heidi Overton to lead FDA” 7
2. 07:00 UTC leadertelegram.com: “Mobile gold miners in eastern Congo complicate health worker efforts to contain Ebola” 3
3. 09:30 UTC Patients and researchers challenge FDA-approved cancer drug dosages 2

Thursday, August 20, 2026

1. 0320:30 UTC

   B. Braun recalls one lot of Excel Lactated Ringers Injection

   2 outlets · first: whio.com Pharma

   Machine summary B. Braun Medical Inc. issued a voluntary recall of one lot of Excel Lactated Ringers Injection, 1000mL, the company announced on the FDA website. The company said the recall was due to the presence of particulate matter and that it has not received reports of adverse events related to the recall.

   1. A company announcement on the FDA website says that B. Braun Medical Inc., based in Bethlehem, Pennsylvania, is voluntarily recalling a single lot of its Excel Lactated Ringers Injection, 1000mL.
   2. That announcement says the cause of the recall is "particulate"; mainly cellulose cotton fibers were identified, and cellulose wood fiber plus polystyrene were identified as other individual particles.
   3. The lot number is J4H077 and the expiration date is Nov. 30, 2026, according to the announcement.
   4. No reports of adverse events tied to the recall have been received by B. Braun, the company reported.
   5. B. Braun said it is informing distributors and customers through the mail, and that it is organizing the return and replacement of every recalled product.

   Reported by whio.com and wftv.com.

   • B. Braun Medical Inc.
   • Excel Lactated Ringers Injection

2. 0422:45 UTC

   Australia releases consultation paper on low carbon liquid fuel demand mechanism

   2 outlets · first: Queensland Country Life Funding

   Machine summary Key facts from the reports:

   1. King said Australia exports around about $5 billion worth of feedstock.

   Reported by Queensland Country Life and The Land.

Friday, August 21, 2026

1. 0518:01 UTC

   Coverage recordSeeking Alpha: “Jupiter Neurosciences announces pricing of $2M registered direct offering”

   2 outlets · first: Seeking Alpha Funding

   Reports ran between 18:01 and 19:15 UTC on Aug 21.

   The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).

   Reported by Seeking Alpha and manilatimes.net.

   • Jupiter Neurosciences

What kind of news was it?

1. Pharma 4
2. Fda approval 4
3. Clinical trial 2
4. Funding 2